Measurement of insulin-like growth factor II (IGF-II) in human serum is complicated by the presence of IGF binding proteins and usually involves cumbersome extraction procedures followed by radioimmunoassay. We have utilized an extraction process developed for measuring insulin-like growth factor II in ovine serum using Sephacryl HR100, and have applied this to the extraction of human samples followed by radioimmunoassay for human IGF-II. The assay yielded 98% recovery of unlabelled IGF-II, parallelism between dilutions of eluate and the standard curve, complete removal of binding proteins and near-complete removal of IGF-I, and intra- and interassay coefficients of variation of 5% and 9%, respectively. The normal range for serum IGF-II in women was 490–1056 μg/L, and IGF-II levels were positively correlated with serum concentrations of insulin-like growth factor binding protein-3 (IGFBP-3) but not with IGF-I levels. Mean serum concentrations of IGF-II were reduced below normal in a number of hypopituitary patients and children with short stature and IGF-II concentrations in these subjects correlated positively with IGF-I and IGFBP-3. In acromegalic patients IGF-II levels were usually normal and were negatively correlated with IGF-I concentrations. From our experience with the above results the present assay appears particularly suitable for clinical measurements and research projects where high sample throughput is required.
RonDPowersACPandianNRGodineJEAxlerodL.Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumour-induced hypoglycaemia. J Clin Endocrinol Metab1989; 68: 701–6.
2.
JorgensenJOLBlumWFMollerNRankeMBChristiansenJS.Short-term changes in insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J Clin Endocrinol Metab1991; 72: 582–7.
3.
SchofieldPNLeeAHillDJCheethamJEJamesDStewartC.Tumour suppression associated with expression of human insulin-like growth factor II. Br J Cancer1991; 68: 687–92.
4.
YeeBCullenKJPaikSPerdueJFHamptonBShwartzKInsulin-like growth factor II mRNA expression in human breast cancer. Cancer Res.1988; 48: 6691–6.
5.
ManniAWeiLBadgerBZaengleinALeightonJShimasakiSExpression of messenger RNA for insulin-like growth factors and insulin-like growth factor binding proteins by experimental breast cancer and normal breast tissue in vivo. Endocrinology1992; 130: 1744–6.
6.
RosenNYeeDLippmanMEParkSCullenKJ.Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat1991; 18: 555–62.
7.
ZapfJWalterHFroeschER.Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycaemia. J Clin Invest1981; 68: 1321–30.
8.
HintzRLLiuF.Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab1977; 45: 988–95.
9.
PowellDRRosenfeldRGBakerBKLiuFHintzRL.Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid chromatographed uremic serum. J Clin Endocrinol Metab1986; 63: 1186–92.
10.
DaughadayWHKapadiaMMarizI.Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. J Lab Clin Med.1987; 109: 355–63.
11.
BowsherRRLeeWHApathyJMO'BrienPJFergusonALHenryDP.Measurement of insulin-like growth factor II in physiological fluids and tissues. 1. An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology1991; 128: 805–14.
12.
ScottCDBaxterRC.Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology1986; 119: 2346–52.
13.
CrawfordBAMartinJLHoweCJHandelsmanDJBaxterRC.Comparison of extraction methods for insulin-like growth factor-I in rat serum. J Endocrinol1992; 134: 169–76.
14.
DaughadayWHMarizIKBlethenSL.Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab1980; 51: 781–8.
15.
MooreLGMylekME.A novel method for the extraction of sheep insulin-like growth factors-I and -II from plasma prior to radioimmunoassay. J Endocrinol1993; 137: 239–45.
16.
BlumWFBreierBH.Radioimmunoassays for IGFs and IGFBPs. Growth Regulat1994; 4 (1): 11–19.
17.
KoeaJBBreierBHShawJHFGluckmanPD.A possible role for IGF-II: evidence for in vivo regulation of IGF-I mediated protein anabolism. Endocrinology1992; 130: 2423–5.
18.
GreenwoodFCHunterWHGloverJS.The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem J1963; 89: 114–23.
19.
LindeSHansenBLernmarkA.Stable iodinated polypeptide hormones prepared by polyacrylamide gel electrophoresis. Anal Biochem1980; 107 (1): 165–76.
20.
SimmonsD.Differences in umbilical cord insulin and birth weight in non-diabetic pregnancies of women from different ethnic groups in New Zealand. Diabetologia1994; 37: 930–6.
21.
GluckmanPDJohnson-BarretTJButlerJEdgarBWGunnTR.Studies of insulin-like growth factors-I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol1983; 19: 405–13.
22.
BlandJMAltmanDG.Statistical methods for assessing agreement between two methods of clinical measurement. Lancet1986; 292: 307–10.
23.
BlumWFGallaherBRankeMB.An IGFBP-blocked IGF-I RIA that measures what it pretends to measure: IGF-I[Abstract]. In: 74th Annual Meeting of the American Endocrine Society.USA: American Endocrine Society, 1992: 293.
24.
OwensPCJohnsonRJCampbellRGBallardFJ.Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. J Endocrinol1990; 124: 269–75.
25.
OwensJAKindKLCarboneFRobinsonJSOwensPC.Circulating insulin-like growth factors-I and -II and substrates in fetal sheep following restriction of placental growth. J Endocrinol1994; 140: 5–13.
26.
LordAPReadLCOwensPCMartinAAWaltonPEBallardFJ.Rapid changes in plasma concentrations of insulin-like growth factor-I (IGF-I), IGF-II and IGF-binding proteins during anaesthesia in young sheep. J Endocrinol1994; 141: 427–37.
27.
QuirkPOwensPMoyseKChinSWallCBallardJInsulin-like growth factors I and II are reduced in plasma from growth retarded children with chronic liver disease. Growth Regul1994; 4 (1): 35–8.
28.
DeyssigRFrischHBlumWFWaldhorT.Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol1993; 128: 313–18.
29.
KubotaTKamadaSTaguchiMAsoT.Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy. Acta Endocrinol1992; 127: 359–65.
30.
HoldawayIMMasonBH.Hormonal factors in the regulation of growth of breast cancer [Abstract 515]. In: Proceedings of the 10th Asia and Oceania Congress of Endocrinology Beijing, Oct 30–Nov 3;China: AOCE, 1994: 37.
